Medable
Medable provides a unified, AI-enabled decentralized clinical trial platform with eCOA, eConsent, and pre-built clinical AI agents for biopharma sponsors, CROs, and emerging biotech across 70+ countries.
- Company typePrivate
- Founded2012
- HeadquartersPalo Alto, United States
- Headcount251–500
- GTM typeB2B
- OfferingSoftware
What Medable does
Medable is a privately held clinical technology company that provides a unified, cloud-agnostic platform for decentralized clinical trials (DCT) and digital data capture, serving biopharmaceutical sponsors, contract research organizations (CROs), and emerging biopharma. Founded in 2012 and headquartered in Palo Alto, California, the company combines eCOA+, eConsent (Total Consent), TeleVisit, BYOD and provisioned devices, and a 400+ instrument validated library across 120+ locales in a single platform deployed in roughly 70+ countries. Medable has grown its customer footprint to include 9 of the top 10 CROs, more than 45 emerging biopharma and biotech accounts, and named top-10 pharmaceutical sponsors across oncology, vaccine, and metabolic indications, with the platform used in nearly 400 trials serving over one million patients globally.
The company's technology stack layers agentic AI on top of its DCT platform through Medable Agent Studio, a no-code agentic AI environment purpose-built for GxP-regulated clinical development. Agent Studio hosts pre-built agents (CRA Agent for clinical monitoring, TMF Agent for trial master file automation, PI Summary Agent for investigator oversight, and DDF Agent for CDISC USDM 4.0 protocol transformation), connects to 30+ clinical and enterprise systems via MCP connectors, and operates over a clinical data ontology layer with human-in-the-loop controls and ALCOA+ audit trails. Revenue is generated primarily through enterprise SaaS subscriptions to the platform and its modules, hardware-based device logistics from six global depots, professional services via the Agentic Accelerator Program, and partnership economics through the CRO Partner Program and Google Cloud Marketplace. Pricing is quote-based with multi-year contracts and a self-serve pricing calculator for CROs; financial scale remains modest in disclosed terms with ~328 employees and reported 2024 revenue of $11.6M (third-party estimate) against approximately $506.6M of cumulative venture funding led by Blackstone Growth, GSR Ventures, and Tiger Global.
Medable firmographics
Firmographics- Name
- Medable
- Legal name
- Medable Inc.
- Website
- https://medable.com
- Company type
- Private
- Founded year
- 2012
- Operating status
- Operating
- Headcount range
- 251–500 employees
- Short description
- Medable provides a unified, AI-enabled decentralized clinical trial platform with eCOA, eConsent, and pre-built clinical AI agents for biopharma sponsors, CROs, and emerging biotech across 70+ countries.
- Ownership category
- akta.pro rank
Medable industry classification
Industry- Product category
- Decentralized Clinical Trial Software Platform
- NAICS
- Software Publishers (5132)
- SIC
- Services-Prepackaged Software (7372)
- akta.pro primary industry
- Medical-Grade Device Connectivity & Device Management (MDM) (HLACAFAG)
- akta.pro secondary industry
- Decentralized & Hybrid Trial Site Services (Home Health/Nursing) (HLAGACAH)
Keywords
Where Medable is headquartered
LocationHeadquarters
- HQ city
- Palo Alto
- HQ country
- United States
- HQ region
- North America
Offices1 record
Markets served
Medable business model
Business model- GTM type
- B2B
- Offering type
- Software
- Cost components
- Personnel, Technology or R&D, Marketing or Sales, Infrastructure, Operations
Revenue model
- SaaS platform subscriptions (Agent Studio, eCOA+, Total Consent, Study Studio): Recurring subscription-based SaaS revenue from sponsors, CROs, and emerging biopharma for use of Medable's unified clinical trial platform, Agent Studio, eCOA+, Total Consent, Study Studio, and analytics. Pricing is quote-based with portal self-serve pricing tools for CROs; land-and-expand across portfolio studies is a key upsell lever.
- Device logistics and provisioning: Revenue from procurement, provisioning, and global delivery of clinical trial devices from six global depots, billed as one all-inclusive monthly rate per device.
- Professional services: Agentic Accelerator Program, integration, change management: High-touch enablement services including onboarding, integration support, governance, change management, dedicated AI clinical development experts, and forward-deployed engineers for sponsor and CRO customers adopting Agent Studio.
- Data and evidence services (decentralized clinical trial data): Participation in the healthcare data monetization ecosystem, leveraging clinical trial data assets for analytics, real-world evidence, and evidence-generation partnerships.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Subscription | Multi-year contract | Quote-based SaaS subscription with CRO self-serve pricing calculator |
| Unit Pricing | Monthly | Device logistics: one all-inclusive monthly rate |
Go-to-market motion5 records
Distribution channels1 record
Marketing channels8 records
Medable product offering
Product offeringCore offering
Medable sells a unified, cloud-agnostic clinical trial platform that combines eCOA+, eConsent (Total Consent), TeleVisit, BYOD/provisioned devices, sensors, and a no-code Study Studio, with an agentic AI layer (Agent Studio) of pre-built and custom AI agents for clinical monitoring, TMF, PI review, and digital data flow. The platform is purpose-built for decentralized clinical trials and sold primarily to biopharma sponsors and CROs.
Product overview
Medable offers a unified clinical trial platform with a platform-plus-modules architecture: the Medable Platform serves as the core, integrating modules including eCOA+ (eCOA/ePRO), Total Consent (eConsent), TeleVisit, Medable Studio (no-code builder), and Medable AI capabilities, with built-in device logistics, BYOD support, and 24/7 global support. Layered on top is Agent Studio (Agent Platform), Medable's no-code agentic AI platform for clinical development, which hosts pre-built AI agents—CRA Agent (Clinical Monitoring), TMF Agent, PI Summary and Review Agent, and DDF Agent—plus a custom agent builder, all powered by MCP connectors to Veeva, Oracle, Medidata, MS 365, Snowflake, and BigQuery. Specialized offerings include the Oncology Solution and Vaccine Solution therapeutic-area packages, the CRO Partner Program, the Agentic Accelerator Program for AI deployment, and the Medable Academy DCT Foundations certification. The platform supports 70+ countries, 120+ locales, 400+ validated instruments, and integrates with enterprise systems while maintaining compliance with HIPAA, GDPR, FDA 21 CFR Part 11, and ICH E6(R2) GCP.
Differentiator
Problem solved
Functional benefit
Brands
- Agent Studio: Medable's no-code agent-builder / agentic AI platform purpose-built for life sciences and clinical development.
- Medable Studio
- eCOA+
- Total Consent
Products and services
- Medable Platform
- Agent Studio (Agent Platform)
- CRA Agent (Clinical Monitoring Agent)
- TMF Agent (eTMF Agent)
- PI Summary and Review Agent
- DDF Agent (Digital Data Flow Agent)
- Medable Studio
- eCOA+ (eCOA/ePRO)
- Total Consent (eConsent)
- Medable AI
- Oncology Solution
- Vaccine Solution
- Long-Term Follow-Up (LTFU) Model for Cell & Gene Therapy
Companies that use Medable
Customer profileNamed customers6 records
Segments5 records
Ideal customer profiles4 records
Medable technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- Yes
- API docs
- API detail
Core technology
AI maturity
App detail
Integration14 records
AI capability11 records
Feature13 records
Medable partnerships and signals
Strategic signalPartnerships
21 partnerships are on record, tiered flagship, core and moderate.
- Google CloudflagshipJoint partnership to deliver Medable's digital clinical trials technology on the Google Cloud Marketplace, enabling sponsors and CROs to procure Medable's solutions through existing Google Cloud relationships and accelerating enterprise adoption.
- CVS HealthflagshipAlliance aimed at tackling diversity in clinical trials by expanding access to underserved populations through CVS Health's retail and care footprint. Operations are reported to span 60 countries alongside this collaboration.
- ICONflagshipJoint execution of a U.S. menopause clinical trial achieving 85% eConsent adoption across 1,200+ participants at 18 sites through tailored site-centric strategies, onboarding, and support.
- Pluto HealthcorePartnership to optimize patient experience and improve access to clinical trials by integrating Pluto Health's patient-data services into Medable's evidence-generation platform.
- MasimocoreIntegration of the Masimo MightySat Rx pulse oximeter into Medable's evidence-generation platform, supporting eight pharmaceutical-sponsored clinical trials across 25 countries with over 3,000 patients in lung and breast cancer.
- Tufts Center for the Study of Drug Development (Tufts CSDD)coreCollaboration on the Medable Innovation Evidence Workshop series focused on DCT impact, adoption, and best practices; first workshop held November 19, 2025 in Boston with leaders from 20 pharma/biotech/CROs plus the FDA and Harvard MRCT.
- Rare Patient VoicemoderateStrategic partnership informing Medable's patient engagement and recruitment strategy alongside the Patient Caregiver Network (PCN) to improve clinical trial access, diversity, retention, and outcomes.
- Ubie (Ubie Pharma Summit, Japan)coreHost of Japan's Ubie Pharma Summit (May 13-14, 2026), where Medable CEO Michelle Longmire was featured as a guest speaker alongside Google and Mayo Clinic leaders at Japan's largest pharmaceutical conference focused on agentic AI in clinical research.
- AccenturecoreListed partner logo in Medable's Mid-to-Large Biopharma ecosystem network; supports enterprise consulting and implementation services alongside Medable's platform.
- Syneos HealthcoreListed partner logo in Medable's Mid-to-Large Biopharma ecosystem network; CRO/biopharma services partner reselling and deploying Medable's digital trial platform.
- CognizantcoreListed partner logo in Medable's Mid-to-Large Biopharma ecosystem network; IT services and consulting partner supporting enterprise deployments.
- PwCcoreListed partner logo in Medable's Mid-to-Large Biopharma ecosystem network; consulting partner supporting strategy, validation, and enterprise adoption.
- PPD (part of Thermo Fisher Scientific)coreTrusted-by CRO partner logo on Medable's CRO Partner Program page; CRO channel reselling and deploying Medable's clinical trial platform to its sponsor clients.
- ParexelcoreTrusted-by CRO partner logo on Medable's CRO Partner Program page; CRO channel reselling and deploying Medable's clinical trial platform to its sponsor clients.
- Veeva SystemscorePrebuilt MCP connector integration with Veeva (including Veeva Vault eTMF) listed as one of 30+ validated connectors that allow Medable agents to act across clinical and enterprise systems.
- OraclecorePrebuilt MCP connector integration with Oracle clinical systems as part of Medable's 30+ validated connector ecosystem, enabling agent interoperability.
- MedidatacorePrebuilt MCP connector integration with Medidata as part of Medable's 30+ validated connector ecosystem for EDC and clinical data interoperability.
- Microsoft (MS 365)coreIntegration with Microsoft 365 collaboration tools (Teams) via Medable's MCP connectors so agents can surface insights and act across enterprise collaboration workflows.
- SnowflakecorePrebuilt connector to Snowflake as part of Medable's 30+ validated connectors, enabling clinical data interoperability across data warehouses.
- OpenTextmoderateMedable's TMF Agent integrates with existing eTMF systems including OpenText to automate 95% of manual TMF document workflows.
- SanofimoderateFeatured in Medable's 'Sponsors talk AI' content series with Sanofi Global Head of Data Architecture, Utilization, and AI Engineering discussing AI integration in clinical trials and agentic AI adoption strategies.
Scale indicators21 records
Recent moves6 records
Expansion highlights7 records
Medable competitors and assessment
Company assessmentBroad incumbents
- Veeva Systems: Dominant life sciences cloud platform with Vault CTMS, eTMF, and eCDMS offerings that compete directly with Medable's clinical operations modules. Medable integrates with Veeva via MCP connectors, positioning it both as competitor and ecosystem partner.
- Oracle Health Sciences (Clinical One): Incumbent EDC, CTMS, and randomization provider for large pharma and CROs, competing with Medable on unified trial platforms. Medable's MCP connector to Oracle clinical systems confirms its role as competitor and partner.
- IQVIA: Largest CRO with proprietary clinical technology (Orchestrated Clinical Trials) and an AI-driven eCOA/DCT stack. Competes with Medable across CRO channel, eCOA, and DCT deployments for biopharma sponsors.
Direct peers
- Medidata (Dassault Systèmes): Direct competitor in eCOA, EDC, and decentralized clinical trial technology, with Rave EDC and a broad sponsor/CRO install base. Medable's MCP connector to Medidata signals both direct competition and interoperability.
- Science 37: Pioneer in decentralized clinical trial orchestration and direct competitor in DCT platform delivery for biopharma sponsors. Comparable in operating model as a DCT-native platform with eCOA, eConsent, and remote nurse capabilities.
- Signant Health: Direct eCOA, eConsent, and patient engagement competitor formed by the merger of CRF Health and Bracket, serving the same top-tier biopharma and CRO customer base as Medable. Competes head-to-head in eCOA build libraries and translation capabilities.
- Clario: Clinical trial endpoint technology provider offering eCOA, imaging, and cardiac safety solutions, with comparable device logistics and global trial expertise. Overlaps with Medable on eCOA, device provisioning, and regulatory-grade data capture.
Emerging players
- ObvioHealth: DCT-focused clinical trial provider competing in decentralized trial design and eCOA, with stronger focus on fully decentralized operational delivery. Comparable in DCT-native positioning but smaller in eCOA library depth.
- Castor: Cloud-native EDC and ePRO platform with growing DCT and eConsent capabilities, targeting emerging biopharma and academic sponsors. Competes with Medable in no-code study building and SMB-to-mid-market trial deployments.
- Curebase: Decentralized clinical trial software platform with site network, competing in DCT delivery for sponsors seeking software-plus-operations offerings. Comparable in DCT-native thesis but smaller scale than Medable's global deployment footprint.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat8 records
Key risks6 records
Key highlights6 records
Customer concentration
Medable social profiles
Digital presenceMedable compliance and trust
Trust signalCompliance7 records
Medable financial estimates
Financial estimateRevenue estimate
Valuation estimate
Medable leadership team
Management profileNumber of profiles
Profiles27 records
Medable funding detail
Funding detailFunding overview
Funding rounds9 records
Investors14 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Medable M&A and investment
M&A and investmentM&A1 record
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Medable
What does Medable do?
Medable sells a unified, cloud-agnostic clinical trial platform that combines eCOA+, eConsent (Total Consent), TeleVisit, BYOD/provisioned devices, sensors, and a no-code Study Studio, with an agentic AI layer (Agent Studio) of pre-built and custom AI agents for clinical monitoring, TMF, PI review, and digital data flow. The platform is purpose-built for decentralized clinical trials and sold primarily to biopharma sponsors and CROs.
Is Medable a public or private company?
Medable is a private company. It is classified as venture growth investor backed and is currently operating.
When was Medable founded?
Medable was founded in 2012. It employs 251 to 500 people.
Where is Medable based?
Medable is headquartered in Palo Alto, United States, in the North America region.
How does Medable make money?
Four revenue lines are on record. SaaS platform subscriptions (Agent Studio, eCOA+, Total Consent, Study Studio) is the primary driver. The others are device logistics and provisioning, professional services: Agentic Accelerator Program, integration, change management and data and evidence services (decentralized clinical trial data).
Who are Medable's main competitors?
Broad incumbents on record are Veeva Systems, Oracle Health Sciences (Clinical One) and IQVIA. Direct peers are Medidata (Dassault Systèmes), Science 37, Signant Health and Clario. Emerging players are ObvioHealth, Castor and Curebase.
Does Medable have an API?
Yes. Medable offers a cloud-agnostic API that integrates clinical and enterprise systems through MCP (Model Context Protocol) connectors and over 30 secure, validated connectors linking Veeva, Oracle, Medidata, MS 365, Snowflake, BigQuery, Salesforce, and collaboration stacks. Medable Agent Studio combines no-code agent creation with MCP connectors across clinical and enterprise systems to automate operational work while maintaining transparency, auditability, and regulatory alignment. Developer documentation is at www.medable.com/platform/agent-studio.
What industry is Medable in?
Medable's product category is Decentralized Clinical Trial Software Platform. Its primary akta.pro industry code is HLACAFAG, Medical-Grade Device Connectivity & Device Management (MDM), with a secondary code of HLAGACAH, Decentralized & Hybrid Trial Site Services (Home Health/Nursing). Its NAICS code is 5132 and its SIC code is 7372.